Krystal Biotech, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Krystal Biotech, Inc. | KRYS - NASDAQ |
$9.00-$11.00 | $10.00 | $10.50 | 3.96 million | 9/20/2017 |
| Ladenburg Thalmann | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2017-08-21 Terms Added 2017-09-07 | ||||||
Krystal Biotech, Inc. Quote & Chart - Click for current quote - KRYS
IPO Boutique aggregates information on public companies and private companies, such as "KRYS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Krystal Biotech, Inc. (adapted from Krystal Biotech, Inc. prospectus):
They are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "KRYS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.